Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

DEFLAZATAB

Class 5Status: Objected
Application Number6165628
Trademark Status
Objected
Trademark Class5
Application Date2023-10-27
Proprietor NameSANTE CARE PHARMACEUTICALS
Appropriate OfficeCHENNAI
StateKERALA
Trademark TypeWORD
User DetailsProposed to be used
Agent NameV.P. BIMALDAS,ADVOCATE[3936]
Agent AddressROOM NO.2, HOTEL WHITE LINES, KALLAI ROAD, CALICUT
Goods And Services Details[CLASS : 5] PHARMACEUTICAL AND MEDICINAL PREPARATIONS, DIETARY SUPPLEMENTS FOR VETERINARY USE , VETERINARY PREPARATIONS

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
DEFLAZATAB5Objected
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about DEFLAZATAB.

What is the status of trademark application 6165628?
The current status of trademark application 6165628 for DEFLAZATAB is Objected.
What is the trademark class of DEFLAZATAB?
DEFLAZATAB is registered under trademark class 5.
Who is the proprietor of DEFLAZATAB?
The proprietor of DEFLAZATAB is SANTE CARE PHARMACEUTICALS.
When was trademark application 6165628 filed?
Trademark application 6165628 for DEFLAZATAB was filed on 2023-10-27.